ACT Oncology President Named EY Entrepreneur Of The Year(R) New Jersey Finalist

New Century

FLEMINGTON, NJ, United States, via ETELIGIS INC., 06/08/2015 – – ACT Oncology (ACT), an oncology-specialist, clinical research organization (CRO), announced today that Patricia Devitt-Risse, Pharm. D, President of the company, has been named a finalist for the Ernst & Young Entrepreneur Of The Year® 2015 Award for the state of New Jersey. With selection administered by a panel of independent judges, this prestigious awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their respective businesses and communities.

Founded by Dr. Devitt-Risse in 2000 and certified as a Women’s Business Enterprise by the State of New Jersey, ACT Oncology is a recognized leader in providing specialized clinical operations services to biotech, pharmaceutical and non-profit oncology organizations throughout the world. Their reputation for having a strong focus on study quality and experienced, stable project teams have made ACT a sought-after oncology development partner, particularly for complex oncology trials and those in need of rescue. A testament to their success is their repeat business and employee retention rate of over 95%.

“I am honored to be named a finalist for this prestigious award,” said Dr. Devitt-Risse. “This company was created with a deep and personal commitment to helping cancer patients in need. Today, I am thrilled at the impact ACT Oncology has had in oncology clinical development, through partnerships with our clients. The continued growth and success of this organization can be greatly attributed to its employees, who share the same passion and commitment for oncology clinical development and entrepreneurial spirit, on which ACT was founded.”

Now in its 29th year, the EY Entrepreneur program has expanded to recognize business leaders in more than 145 cities in more than 60 countries throughout the world.

The Ernst & Young Entrepreneur Of The Year® 2015 Award will be announced at the annual awards gala in Palm Springs, California, on November 14, 2015. The awards are the culminating event of the EY Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.


Founded and produced by EY, the Entrepreneur Of The Year Awards are sponsored nationally by the Ewing Marion Kauffman Foundation and SAP America. In New Jersey, sponsors also include Cresa, DLA Piper, Empire Valuation Consultants, Merrill Corporation, Morgan Lewis, Murray Devine, NJ BIZ, PNC, Scherzer International, SolomonEdwardsGroup.

About EY Entrepreneur Of The Year®:

EY Entrepreneur Of The Year is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries.

About EY:

EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services EY delivers help build trust and confidence in the capital markets and in economies the world over. They develop outstanding leaders who team to deliver on promises to all of its stakeholders. In so doing, EY plays a critical role in building a better working world for its people, its clients and for communities.

About ACT Oncology:

ACT Oncology is a full-service CRO, specializing in providing outstanding, cost-effective and responsive oncology drug development support for biotech, pharmaceutical and non-profit oncology organizations. Our team of clinical research experts is dedicated to supporting our Sponsors’ Phase I-III oncology programs, registries and Investigator Sponsored Trials for hematologic and solid tumor indications.

Services offered by ACT Oncology include: Study Consultation and Feasibility, Study Start-up, Project Management, Global Trial Implementation and Management, Clinical Monitoring, Site Management, Medical Monitoring, Safety Reporting, Data Management, Clinical Programming, Statistical Analysis and Reporting, Study Quality Metrics and Regulatory and Compliance Consulting


Jen Mahoney

Company: ACT Oncology

Tel: 484-744-3522

Email: jen.mahoney

SOURCE: ACT Oncology

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s